Nov 9, 2022: NRP-DCD Heart Transplantation: An Innovative Approach to Expanding Donor Access

CAMBRIDGE, MASSACHUSETTS – Paragonix Technologies, Inc., a leader in Advanced Organ (AOP) technology, is glad to announce that we are sponsoring the NRP-DCD Heart Transplantation: An Innovative Approach to Expanding Donor Access and support the event on Nov 9, 2022.

Some transplant centers are working from the ground up and are unsure of how to best implement a successful DCD-NRP program. Bearing this in mind, we will be joined by Dr. Brian Lima from the Medical City Heart Hospital in Dallas who will review the fundamentals of Donation after Brain Death (DBD) vs. Donation After Circulatory Determination of Death (DCDD). He will provide a comprehensive overview of the surgical and logistical basics of the NRP-DCD approach and will highlight the potential benefits from the transplant perspective. Ultimately, during this discussion, we will explore effective strategies for the implementation process, while evaluating the successes, challenges, and potential opportunities for improvement as it relates to DCD-NRP for donor heart transplantation

For more information about Paragonix, visit www.paragonix.com.

About Paragonix Technologies

Paragonix Technologies creates organ transportation devices that safeguard organs during the journey between donor and recipient patients. Our devices incorporate clinically proven and medically trusted cold preservation techniques in a novel suspension system to provide unprecedented physical and thermal protection. Paragonix is a leading provider of FDA cleared and CE marked transport devices for organ preservation.

Connect with us on LinkedIn: Paragonix Technologies

Like Us on Facebook: Paragonix SherpaPak

L-399 Rev 1

Contacts

Media Contact

Adam Lafreniere, Sr. Director, Marketing

marketing@paragonixtechnologies.com

FlightAware® is a registered trademark of FlightAware, a division of Collins Aerospace